Article
[Understanding and therapeutic targeting of aberrant mRNA splicing mechanisms in oncogenesis].
[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Jan 2020
Tanaka Atsushi, Kobayashi Susumu, Xiao Muran, Inoue Daichi
Abstract excerpt
Splicing factor 3b subunit 1 (SF3B1) is the most commonly mutated RNA splicing factor identified in myelodysplastic syndrome (MDS), chronic lymphocytic leukemia, and uveal melanoma. The mechanisms by which SF3B1 mutations promote malignancy are poorly understood. Here, we integrated pan-cancer RNA sequencing to identify mutant SF3B1-dependent aberrant splicing events with a positive CRISPR screen to prioritize...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
